Clinical Trial

International Bifurcation Study

Study acronym: IBS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2019 (before its estimated December 31, 2021 completion). Its status may not reflect the trial's current state.
Summary
The IBS registry is an observational, multi-center, real-world registry of stenting in coronary bifurcation lesions that will collect information on procedures and outcomes from various participating centers. The aim of this registry is to investigate long-term clinical results and predictors of adverse outcomes after PCI for coronary bifurcation lesions among various participating centers.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2018-02-28.
Trial Details
NCT Number NCT03450577
Lead Sponsor Meshalkin Research Institute of Pathology of Circulation
Conditions Coronary Bifurcation Lesion
Enrollment 5,000 participants
Start Date 2018-01-01
Primary Completion 2021-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2019-03-11